Frequently Asked Questions

This content has been reviewed and approved by

Daniel P. Petrylak, MD
Associate Professor of Medicine
Director, Genitourinary Oncology Program
Columbia University Medical Center
 

Our oncologists have been asked many questions specific to prostate cancer. In this section, they provide answers to the questions that patients ask most often.

Here is a recent question and answer. To see more FAQs, choose one of the links below.

Question: I have an enlarged prostate as well as localized prostate cancer. Someone in my prostate cancer support group mentioned that hormonal therapy would be helpful to take before my radical prostatectomy. Is it useful to take hormonal therapy before surgery?

Answer: Thus far, there has been evidence that the tumor may be down-staged if hormonal therapy is given before surgery. However, time to PSA progression has not been changed with hormonal therapy before radical prostatectomy versus prostatectomy alone. Therefore, most urologists do not recommend taking hormonal therapy before this surgery.

More FAQs in Prostate Cancer

Diagnosis 

Watchful Waiting 

Chemotherapy 

Hormonal Therapy 

Radiation 

Surgery 

Salvage Therapy 

Metastatic Disease 

Nutrition 

Prevention 

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Prostate Cancer News
CORRECTION: Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Seed therapy for prostate cancer may zap fertility

February 1, 2012 — NEW YORK (Reuters Health) - Radioactive "seeds" that are sometimes used to treat early prostate cancer may do widespread damage to the DNA in a man's sperm, a small study finds.

Statins tied to lower risk of fatal prostate cancer

December 29, 2011 — NEW YORK (Reuters Health) - In a new study of middle-aged New Jersey men, taking cholesterol-lowering drugs was linked to a lower chance of dying from prostate cancer.

Select news items provided by Reuters Health